Psoriasis is an immunodysregulatory inflammatory disease associated with comorbidities impacting quality of life. With the advent of new treatments, there is growing need to assess the long term safety and efficacy of treatments in a real-world setting.
http://ift.tt/2ifHXc1
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου